These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 17384922
1. Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display. Bussolati B, Grange C, Tei L, Deregibus MC, Ercolani M, Aime S, Camussi G. J Mol Med (Berl); 2007 Aug; 85(8):897-906. PubMed ID: 17384922 [Abstract] [Full Text] [Related]
2. Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154. Deambrosis I, Lamorte S, Giaretta F, Tei L, Biancone L, Bussolati B, Camussi G. J Mol Med (Berl); 2009 Feb; 87(2):181-97. PubMed ID: 18985310 [Abstract] [Full Text] [Related]
3. Altered angiogenesis and survival in human tumor-derived endothelial cells. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G. FASEB J; 2003 Jun; 17(9):1159-61. PubMed ID: 12709414 [Abstract] [Full Text] [Related]
4. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo. Rastelli L, Valentino ML, Minderman MC, Landin J, Malyankar UM, Lescoe MK, Kitson R, Brunson K, Souan L, Forenza S, Goldfarb RH, Rabbani SA. Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086 [Abstract] [Full Text] [Related]
5. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. Liang S, Lin T, Ding J, Pan Y, Dang D, Guo C, Zhi M, Zhao P, Sun L, Hong L, Shi Y, Yao L, Liu J, Wu K, Fan D. J Mol Med (Berl); 2006 Sep; 84(9):764-73. PubMed ID: 16763842 [Abstract] [Full Text] [Related]
14. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis. Thapa N, Hong HY, Sangeetha P, Kim IS, Yoo J, Rhee K, Oh GT, Kwon IC, Lee BH. J Control Release; 2008 Oct 06; 131(1):27-33. PubMed ID: 18680772 [Abstract] [Full Text] [Related]
15. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Geninatti Crich S, Bussolati B, Tei L, Grange C, Esposito G, Lanzardo S, Camussi G, Aime S. Cancer Res; 2006 Sep 15; 66(18):9196-201. PubMed ID: 16982763 [Abstract] [Full Text] [Related]
16. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Lee SM, Lee EJ, Hong HY, Kwon MK, Kwon TH, Choi JY, Park RW, Kwon TG, Yoo ES, Yoon GS, Kim IS, Ruoslahti E, Lee BH. Mol Cancer Res; 2007 Jan 15; 5(1):11-9. PubMed ID: 17259343 [Abstract] [Full Text] [Related]
17. A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library. Brown CK, Modzelewski RA, Johnson CS, Wong MK. Ann Surg Oncol; 2000 Dec 15; 7(10):743-9. PubMed ID: 11129422 [Abstract] [Full Text] [Related]
19. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides. Trepel M, Pasqualini R, Arap W. Methods Enzymol; 2008 Dec 15; 445():83-106. PubMed ID: 19022056 [Abstract] [Full Text] [Related]
20. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer]. Wang Y, Wu KC, Nie YZ, Han ZY, Han QL, Qiao TD, Fan DM. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep 15; 19(5):469-72. PubMed ID: 15169660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]